Literature DB >> 21084313

Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.

William D Knight1, Aren A Okello, Natalie S Ryan, Federico E Turkheimer, Sofia Rodríguez Martinez de Llano, Paul Edison, Jane Douglas, Nick C Fox, David J Brooks, Martin N Rossor.   

Abstract

(11)Carbon-Pittsburgh compound B positron emission tomography studies have suggested early and prominent amyloid deposition in the striatum in presenilin 1 mutation carriers. This cross-sectional study examines the (11)Carbon-Pittsburgh compound B positron emission tomography imaging profiles of presymptomatic and mildly affected (mini-mental state examination ≥ 20) carriers of seven presenilin 1 mutations, comparing them with groups of controls and symptomatic sporadic Alzheimer's disease cases. Parametric ratio images representing (11)Carbon-Pittsburgh compound B retention from 60 to 90 min were created using the pons as a reference region and nine regions of interest were studied. We confirmed that increased amyloid load may be detected in presymptomatic presenilin 1 mutation carriers with (11)Carbon-Pittsburgh compound B positron emission tomography and that the pattern of retention is heterogeneous. Comparison of presenilin 1 and sporadic Alzheimer's disease groups revealed significantly greater thalamic retention in the presenilin 1 group and significantly greater frontotemporal retention in the sporadic Alzheimer's disease group. A few individuals with presenilin 1 mutations showed increased cerebellar (11)Carbon-Pittsburgh compound B retention suggesting that this region may not be as suitable a reference region in familial Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084313     DOI: 10.1093/brain/awq310

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  40 in total

1.  Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.

Authors:  Burcu Zeydan; Val J Lowe; Christopher G Schwarz; Scott A Przybelski; Nirubol Tosakulwong; Samantha M Zuk; Matthew L Senjem; Jeffrey L Gunter; Rosebud O Roberts; Michelle M Mielke; Eduardo E Benarroch; Moses Rodriguez; Mary M Machulda; Timothy G Lesnick; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci; Orhun H Kantarci
Journal:  Mult Scler       Date:  2017-05-05       Impact factor: 6.312

Review 2.  The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?

Authors:  Adriana P Hermida; William M McDonald; Kyle Steenland; Allan Levey
Journal:  Expert Rev Neurother       Date:  2012-11       Impact factor: 4.618

3.  Disruption of thalamic connectivity in Alzheimer's disease: a diffusion tensor imaging study.

Authors:  Qing-Yong Zhu; Si-Wei Bi; Xiu-Ting Yao; Zhi-Yan Ni; Ying Li; Bo-Yu Chen; Guo-Guang Fan; Xiu-Li Shang
Journal:  Metab Brain Dis       Date:  2015-07-04       Impact factor: 3.584

4.  Perspective: prevention is better than cure.

Authors:  Sam Gandy
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

5.  Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease.

Authors:  Aditi Joshi; John M Ringman; Albert S Lee; Kevin O Juarez; Mario F Mendez
Journal:  J Neurol       Date:  2012-03-30       Impact factor: 4.849

Review 6.  Immunotherapy for Alzheimer disease: the challenge of adverse effects.

Authors:  Yu-Hui Liu; Brian Giunta; Hua-Dong Zhou; Jun Tan; Yan-Jiang Wang
Journal:  Nat Rev Neurol       Date:  2012-07-03       Impact factor: 42.937

Review 7.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

Review 8.  Rethinking on the concept of biomarkers in preclinical Alzheimer's disease.

Authors:  Valentina Berti; Cristina Polito; Gemma Lombardi; Camilla Ferrari; Sandro Sorbi; Alberto Pupi
Journal:  Neurol Sci       Date:  2016-01-20       Impact factor: 3.307

9.  Relationship of regional brain β-amyloid to gait speed.

Authors:  Natalia Del Campo; Pierre Payoux; Adel Djilali; Julien Delrieu; Emiel O Hoogendijk; Yves Rolland; Matteo Cesari; Michael W Weiner; Sandrine Andrieu; Bruno Vellas
Journal:  Neurology       Date:  2015-12-07       Impact factor: 9.910

10.  Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.

Authors:  Mitsuru Shinohara; Shinsuke Fujioka; Melissa E Murray; Aleksandra Wojtas; Matthew Baker; Anne Rovelet-Lecrux; Rosa Rademakers; Pritam Das; Joseph E Parisi; Neill R Graff-Radford; Ronald C Petersen; Dennis W Dickson; Guojun Bu
Journal:  Brain       Date:  2014-03-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.